US EditionTrump signs memo to crack down on direct-to-consumer pharma ads
The Trump administration targets deceptive drug ads by enforcing existing rules and issuing thousands of warning letters to improve transparency and protect consumers from misleading information.
- President Donald Trump signed a memorandum to increase scrutiny on pharmaceutical ads, aiming for greater enforcement of regulations on drug advertising, as reported by administration officials.
- The U.S. Food and Drug Administration plans to eliminate a provision that allowed reduced disclosures in ads, aiming for more transparency.
- The administration will send over 100 cease-and-desist letters and thousands of warning letters to ensure compliance with existing regulations, according to a senior administration official.
- Trump's administration emphasized the need for accurate drug information to consumers, as ads have increasingly misled the public regarding side effects, a senior White House official stated.
70 Articles
70 Articles
The Virginian Pilot
Trump’s plan for a drug advertising crackdown faces many hurdles
By MATTHEW PERRONE WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including pushback from industry and layoffs among regulators tasked with leading the effort. Related Articles Appeals court upholds NJ’s ban on carrying firearms in sensitive places, after VA upheld similar ruling …
How Trump Wants to Upend TV Drug Ads
Hi, it’s Cynthia and Rachel. Near-ubiquitous television drug advertising in the US full of bizarre side effects like “may cause death” has for years provided fodder for hilarious Saturday Night Live sketches. After President Donald Trump weighs in, Americans might end up hearing about even more side effects. More on that in a moment...
Trump Cracks Down on Drug Ads
Donald Trump is ramping up pressure on drug companies to be more transparent about the risks associated with their prescription products. In a memorandum signed on Tuesday, the President ordered federal health agencies to enforce existing rules about misleading prescription drug advertisements. The order falls short of Health and Human Services Secretary Robert F. Kennedy Jr.’s pledge on the campaign trail last year to altogether “ban pharmaceut…
Coverage Details
Bias Distribution
- 52% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
